Industry

DUBLIN–(BUSINESS WIRE)–The “Global In Vivo CRO Market Size, Share & Trends Analysis Report by Type (Rodent, Non-Rodent), by GLP Type (Non-GLP, GLP Toxicology), by Indication (Pain Management, Oncology), by Region (North America, APAC), and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The global in vivo CRO market size is expected to reach … [Read more…]

Nearly half of all consumers surveyed say that their premiums have increased in the past year Fifteen percent don’t trust any insurance providers BERLIN–(BUSINESS WIRE)–A recent survey reveals that consumers all over the world are worried about the rising cost of insurance premiums. Among the American consumers surveyed, 70% indicate that they are worried about … [Read more…]

Solidifying expertise in high-impact trauma and fragility fractures of the pelvis BELLEVUE, Wash.–(BUSINESS WIRE)–#CurvaFixImplant—CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the addition of three new members to its Surgeon Advisory Board. The new members bring together expertise in orthopedic traumatology, pelvis and acetabular trauma reconstruction, and Fragility … [Read more…]

Livara’s owned and operated SpineZone clinics will continue to provide musculoskeletal support throughout Southern California SAN DIEGO–(BUSINESS WIRE)–Today, orthopedic whole health company Livara announced its launch as an interdisciplinary orthopedic care management system working with payors, providers, and health systems to mend the gaps in musculoskeletal (MSK) care. Livara’s owned and operated clinics under the … [Read more…]

Investment from SK Capital to support Apotex’s next phase of growth and continued innovation for patient affordability NEW YORK–(BUSINESS WIRE)–An affiliate of funds advised by SK Capital Partners, LP (“SK Capital”) announced today that it has reached an agreement to acquire Apotex Pharmaceutical Holdings Inc. (“Apotex” or the “Company”), a proudly Canadian, global pharmaceutical company … [Read more…]

Addition Reflects the Continued Growth of the Boston Office and Sustained Demand for Transactional Experience Among Technology and Life Sciences Clients Wilson Sonsini Recently Added Seth Flaum in New York as a Partner in the Technology Transactions Department PALO ALTO, Calif.–(BUSINESS WIRE)–Wilson Sonsini Goodrich & Rosati, the premier provider of legal services to technology, life … [Read more…]

NEW YORK–(BUSINESS WIRE)–#biotech—Castor, a leading provider of clinical trial technology to democratize clinical research, today announced the appointment of Andrew Sadler as Chief Product & Technology Officer (CPTO). “Castor’s modular SaaS platform improves the clinical trial experience for patients, sites and sponsors, using technology to accelerate every step of the clinical trial journey,” said Derk … [Read more…]

— Preliminary data from the ongoing Phase 1b study shows RLYB212 rapidly and completely eliminates transfused HPA-1a positive platelets — — Proof-of-Concept Data Expected in 1Q 2023 — NEW HAVEN, Conn.–(BUSINESS WIRE)–Rallybio Corporation (Nasdaq: RLYB) today announced positive preliminary results from its ongoing Phase 1b proof-of-concept study of RLYB212, an anti-HPA-1a monoclonal antibody for the … [Read more…]

carafem is increasing access to medically supported, at-home abortion care beginning Sept. 27 WASHINGTON–(BUSINESS WIRE)–Client-centered medically supported telehealth abortion care provider, carafem, proudly announces the expansion of telehealth abortion care services to Minnesota – providing people with safe, affordable, high-quality abortion care without the need to travel to a clinic to terminate a pregnancy up … [Read more…]

Funding is being used to discover and develop a broad pipeline of precision TYK2 therapeutics MENLO PARK, Calif.–(BUSINESS WIRE)–#SeriesA—Sudo Biosciences (“Sudo”), a biopharmaceutical company committed to designing and developing a broad pipeline of best-in-class precision TYK2 (tyrosine kinase 2) inhibitors, today announced the close of $37M in Series A financing led by Frazier Life Sciences … [Read more…]